injectable glp-1 agonists for Weight Loss: Safe or Risky? How GLP-1 medications are transforming
Description
CMC Weight Loss is helping patients with GLP-1 options utilizing Medicare initiatives that make life-changing medications more affordable.
Shima Hadidchi, MD, in Apple Valley and Victorville, CA
Participants Patients with type 2 diabetes
Newly released clinical trial data on the GLP-1 agonist drug Wegovy found that weight loss was sustained for up to four years after participants started taking the once-weekly injected medication
Each is doctor-formulated to support your wellness needs during weight loss.*
It is a monosaccharide, which means it is a single sugar molecule
